Xtandi Congressional Letter and CFO Change a Modest Negative at Worst for Medivation (MDVN) - UBS
Tweet Send to a Friend
UBS Analyst, Matthew Roden, sees the Medivation (NASDAQ: MDVN) CFO change as a positive and the Congressional letter threatening Xtandi ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
